Oxprenolol Hydrochloride is a non-selective
beta-adrenergic receptor antagonist, commonly known in the market under trade names like Trasor, Coretal, and others. This drug belongs to a class of medications known as beta-blockers and primarily targets the heart and circulation system. Oxprenolol Hydrochloride works by blocking the effects of
adrenaline on the heart and blood vessels, thereby reducing heart rate, cardiac output, and blood pressure. Research institutions have focused extensively on its utility in treating various cardiovascular conditions, including
hypertension,
angina pectoris, and certain arrhythmic disorders.
The drug has been around for several decades and has been the subject of numerous clinical trials and studies aimed at understanding its efficacy, safety profile, and mechanism of action. Despite the introduction of newer beta-blockers, Oxprenolol Hydrochloride remains a valuable therapeutic option, especially for patients who may be intolerant to more selective beta-blockers.
Oxprenolol Hydrochloride Mechanism of Action
The mechanism of action of Oxprenolol Hydrochloride involves its role as a competitive antagonist to beta-adrenergic receptors, specifically
beta-1 and
beta-2 receptors found in the heart and vascular smooth muscle. By blocking these receptors, Oxprenolol Hydrochloride inhibits the usual sympathetic nervous system stimulation. This results in a decrease in heart rate (negative chronotropic effect), a reduction in the force of heart muscle contraction (negative inotropic effect), and a lowering of the rate of electrical conduction through the heart (negative dromotropic effect).
Furthermore, the drug also reduces the release of
renin, an enzyme that plays a key role in the regulation of blood pressure. By suppressing renin activity, Oxprenolol Hydrochloride contributes to a decrease in blood pressure. Additionally, there is some evidence suggesting that Oxprenolol Hydrochloride may exert partial agonist activity at beta-adrenergic receptors, a feature that may account for fewer adverse metabolic effects compared to pure beta-blockers.
How to Use Oxprenolol Hydrochloride
Oxprenolol Hydrochloride is available in various formulations, including tablets and extended-release capsules. The method of administration is typically oral, and the dosage can vary depending on the specific condition being treated, the severity of the condition, and the patient's response to the medication.
For hypertension, the usual starting dose is 20 mg taken 2 to 3 times daily, which may be adjusted based on the patient's blood pressure response. For angina, the dosage may range from 20 mg to 80 mg taken 2 to 3 times daily. It is crucial to follow the prescribing healthcare provider's instructions closely, as improper dosage can lead to suboptimal therapeutic effects or heightened risk of adverse reactions.
The onset of action for Oxprenolol Hydrochloride is generally within 1 to 2 hours after oral administration, with peak plasma concentrations achieved within 2 to 4 hours. The duration of effect varies, but the drug typically needs to be administered multiple times a day due to its relatively short half-life. Extended-release formulations are available to allow for once-daily dosing, which can improve patient adherence to the treatment regimen.
What is Oxprenolol Hydrochloride Side Effects
Like all medications, Oxprenolol Hydrochloride can cause side effects. Common side effects include
dizziness,
fatigue, and gastrointestinal disturbances such as
nausea and
diarrhea. Some patients may experience a
slow heart rate (bradycardia) or
low blood pressure (hypotension).
Serious but less common side effects include
bronchospasm, particularly in individuals with a history of
asthma or
chronic obstructive pulmonary disease (COPD), as the drug also blocks beta-2 receptors in the lungs. Additionally, some patients may experience worsening of
heart failure symptoms, or in rare cases, severe
allergic reactions characterized by
rash,
itching, or
swelling.
There are also several contraindications for the use of Oxprenolol Hydrochloride. It should not be used in patients with known hypersensitivity to the drug or any of its components. It is also contraindicated in individuals with severe bradycardia,
second- or third-degree heart block,
cardiogenic shock, and uncontrolled heart failure. Caution is advised when prescribing this medication to patients with a history of respiratory disorders,
diabetes (as it may mask
hypoglycemic symptoms), and
peripheral vascular disease.
What Other Drugs Will Affect Oxprenolol Hydrochloride
Oxprenolol Hydrochloride can interact with other medications, potentially altering its effectiveness or increasing the risk of adverse effects. One critical interaction to consider is with other antihypertensive drugs, which can lead to an additive effect and result in excessive lowering of blood pressure. Therefore, close monitoring and possible dose adjustments are necessary when Oxprenolol Hydrochloride is used in combination with other blood pressure-lowering agents.
Drugs that affect the
cytochrome P450 enzyme system, particularly
CYP2D6 inhibitors such as
quinidine,
fluoxetine, and
paroxetine, can increase plasma concentrations of Oxprenolol Hydrochloride, heightening the risk of side effects. Conversely, CYP2D6 inducers may reduce the effectiveness of the medication by lowering its plasma levels.
Nonsteroidal anti-inflammatory drugs (NSAIDs) can attenuate the antihypertensive effects of Oxprenolol Hydrochloride, making it less effective in controlling blood pressure. Additionally, concurrent use of beta-blockers with calcium channel blockers like
verapamil or
diltiazem can lead to additive heart rate and blood pressure effects, increasing the risk of bradycardia or
heart block.
Patients taking antidiabetic medications should be aware that Oxprenolol Hydrochloride can mask the signs and symptoms of hypoglycemia, such as rapid heart rate. Thus, careful monitoring of blood glucose levels is essential, and adjustments to the diabetes treatment regimen may be necessary.
Lastly, medications that possess negative inotropic effects, such as antiarrhythmics, should be used cautiously with Oxprenolol Hydrochloride to avoid exacerbating heart failure or causing severe bradycardia.
In conclusion, Oxprenolol Hydrochloride is a non-selective beta-blocker effective in treating various cardiovascular conditions by reducing heart rate and blood pressure. While generally safe when used appropriately, it requires careful consideration of dosage, potential side effects, contraindications, and drug interactions to maximize its therapeutic benefits while minimizing risks.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


